Sacubitril Valsartan Enhances Cardiac Function and Alleviates Myocardial Infarction in Rats through a SUV39H1/SPP1 Axis

Sacubitril valsartan (lcz696) has been demonstrated as a substitute for angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the treatment of heart failure. This research is aimed at examining the effects of lcz696 and its target molecules on myocardial infarction (MI). A r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jian-Fen, Fan, Zhong-Bao, Wu, Chun-Wei, Qi, Guo-Xian, Cao, Qiu-Yu, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526637/
https://www.ncbi.nlm.nih.gov/pubmed/36193085
http://dx.doi.org/10.1155/2022/5009289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526637/
https://www.ncbi.nlm.nih.gov/pubmed/36193085
http://dx.doi.org/10.1155/2022/5009289

Ejemplares similares